Active Ingredient(s): Amantadine
FDA Approved: * August 24, 2017
Pharm Company: * ADAMAS PHARMA LLC
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Gocovri Overview

Amantadine, sold under the brand name Gocovri among others, is a medication used to treat dyskinesia associated with parkinsonism and influenza caused by type A influenzavirus, though its use for the latter is no longer recommended due to widespread drug resistance.[3][4] It acts as a nicotinic antagonist, dopamine agonist, and noncompetitive NMDA antagonist.[5][6] The antiviral mechanism of action is antagonism of the influenzav...

Read more Gocovri Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Amantadine

Recent Gocovri Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 100mg
  • Capsule, Extended Release: 137mg, 68.5mg
  • Syrup: 50mg/5ml, 50mg/ml
  • Tablet: 100mg
  • Tablet, Extended Release: 129mg, 161mg, 193mg, 258mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Gocovri: (2 results)

Sorted by National Drug Code
  • 70482-085 Gocovri 68.5 mg Oral Capsule, Coated Pellets by Adamas Pharma, LLC
  • 70482-170 Gocovri 137 mg Oral Capsule, Coated Pellets by Adamas Pharma, LLC

Other drugs which contain Amantadine or a similar ingredient: (3 results)